Latest News
-
How long is too long? Rethinking the Huntington’s disease ‘gray area’
Does an ‘intermediate’ CAG repeat count in the Huntington’s disease gene cause brain changes?
-
Can sad mice help treat Huntington's disease?
What can we learn about depression symptoms in HD by studying mice – how do you know a mouse is even sad?
-
Gene silencing drug safe in ALS patients… bring on Huntington's disease trials
Gene silencing drug injected into spinal fluid in ALS patients proves safe. Good news for similar planned HD trials.
-
A DNA repair protein modifies the stability of long CAG tracts in the Huntington's disease gene
DNA repair is a critical process to cells, but errors in this process might explain 'repeat instability' in HD
-
Landmark study puts Huntington's disease trials on TRACK
Final results from the TRACK-HD study show very specific changes in HD. We're ready for trials: bring on the drugs!
-
Splicing with danger: a new way of thinking about the harmful Huntington's disease protein
Researchers discover a new way harmful fragments of the huntingtin protein are made in neurons.
-
Proposed Huntington's disease 'biomarker' is not useful, new study suggests
New study shows a blood chemical called '8OHdG' is not a good biomarker for HD. Bad news?
-
Is access to predictive genetic testing for Huntington's disease a problem?
Is access to predictive genetic testing for Huntington's disease a problem? A UBC study says it is.
-
HD Therapeutics Conference 2013 Updates: Day 3
Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013
-
HD Therapeutics Conference 2013 Updates: Day 2
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference